زينيكوين
Zeniquin (marbofloxacin) is a potent synthetic broad-spectrum fluoroquinolone bactericidal antimicrobial for oral administration in dogs and cats. Indicated for the treatment of bacterial infections of the skin and soft tissue, urinary tract infections, and bacterial feline skin infections associated with susceptible organisms.
الشكل الصيدلاني
Tablet
نوع المنتج
دواء
الشركة المصنعة
الحجم
Bottles of 50 or 100 scored tablets (25 mg, 50 mg, 100 mg, and 200 mg)
| النوع الحيواني | الجرعة | طريقة الإعطاء | المدة |
|---|---|---|---|
| Dog | 2.75 to 5.5 mg marbofloxacin/kg body weight once daily | Oral (PO) | Once daily for 7 to 30 days depending on infection site and response |
| Cat | 2.75 to 5.5 mg marbofloxacin/kg body weight once daily | Oral (PO) | Once daily for up to 30 days |
لا توجد معلومات سحب متاحة.
Treatment of skin and soft tissue infections (wounds, abscesses, cellulitis) in dogs and cats caused by susceptible bacteria.
Treatment of urinary tract infections (cystitis) in dogs caused by susceptible strains of E. coli and Proteus mirabilis.
Do not use in immature, growing dogs (less than 12-18 months) due to potential cartilage erosion in weight-bearing joints.
Do not exceed recommended dose in cats due to risk of fluoroquinolone-induced retinopathy.
Use with caution in animals with known Central Nervous System (CNS) disorders or epilepsy.
Ensure adequate hydration during treatment.
Mild gastrointestinal upset (decreased appetite, vomiting, soft stools); rare neurotoxicity or lethargy.
Zeniquin Prescribing Information
نشرةلا توجد أمراض مرتبطة.
لا توجد بيانات
لم تتم إضافة المعلومات بعد.
شركة مصنعة
لا توجد بدائل متاحة.